Huber needles are used in combination with a port inserted in the body of a chronically sick patient to achieve repeated access to veins for blood removal and injection of drugs, blood products, and dietary solutions. These needles are made to pierce the port without causing it to dislodge. Hospitals, oncology departments, laboratories, and ambulatory surgical centers all use Huber needles. Medication and diet injection, blood withdrawal, and imaging fluid infusion are all done with these needles.
The global Huber needles market is expected to account around US$ 66.1 Mn in terms of value and over 51,270,030 Units in terms of volume by the end of 2027.
Rising incidences of cancer is expected to propel growth of the global Huber needles market over the forecast period. For instance, according to the World Health Organization (WHO), around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018.
Request a FREE sample copy – Huber Needles market report click here: https://www.coherentmarketinsights.com/insight/request-sample/3648
Furthermore, vascular access needles have a desirable reimbursement possibility, which is also expected to drive growth of the global Huber needles market over the forecast period. For instance, according to the Center of Medicare and Medicaid Services (CMS), Supplies including Huber needles, IV setup, butterfly set, gauze, syringes, and catheters are reimbursed for chemotherapy administration procedures. Commercial players also repay things like syringes and needles (including Huber needles).
North America region held a significant position in the global Huber needles market in 2019, accounting around 42.1% share in terms of value, followed by Europe.
Huber needles which are associated with an increased risk of infection, is expected to hinder growth of the global Huber needles market over the forecast period. The caregiver must repeatedly reach the inserted port and pierce a silicon septum with a non-corning Huber needle while using Huber needles. And during removal of the Huber needles, there is a high chance of needle stick injury.
IV Cancer Application segment in the global Huber needles market was accounted around US$ 16.8 Mn in 2019 and is estimated to reach over US$ 29.4 Mn by 2027 at a CAGR around 7.2% over the forecast period.
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3648
Companies have produced and launched numerous needles with improved safety features in the industry as a result of the increased emphasis on minimizing needle stick accidents. Advanced features such as self-retracting needles and needles with safety locking are becoming more common among healthcare providers and patients.
Furthermore, rising incidences of HIV and blood-borne disorders has also led manufacturers to develop safe needles, which is also expected to drive growth of the global Huber needles market over the forecast period. For instance, according to Joint United Nations Program on HIV/AIDS, 37.9 million people globally were living with HIV at the end of 2018.
Rising incidences of end-stage renal disorders is expected to drive growth of the global Huber needles market over the forecast period. For instance, according to November 2019 data of National Center for Biotechnology Information, End-stage renal failure is increasing at a steady rate of around 20,000 cases per year.
Key players in the global Huber needles market are concentrating on various marketing initiatives to broaden their customer base. For instance, in February 2020, Baxter International Inc. presented at the 9th Annual SVB Leerink Global Healthcare Conference in New York, N.Y.
- The U.S. FDA authorizes the use of Huber needles for long term medication infusion and blood withdrawal
- Huber needles are type of safety vascular access needles that fall under class II with special controls. However, companies need a premarket approval before commercializing the device.
- FDA mandates performance tests for stiffness, bending breakage, corrosive resistance and elasticity of Huber needles
- Huber needle manufacturers are expected to submit performance tests in investigational device exemption applications (IDEs) and premarket approval applications (PMAs) to support the safety and effectiveness of Huber needles. These devices require a premarket approval (PMA) application before marketing and commercialization.
- According to the U.S. FDA, the basic structure of Huber needle contains needle, needle cap and needle hub. These needles are either straight type available in gauges 19, 20, and 22, and length 1’’ to 1-1/2’’ or bent 90 degree angle available in gauges 19, 20, and 22, and length 1’’ to 1-1/2’’
- FDA has set few standard guideline in order to meet the safety requirement. These devices falls under the category of class II devices (Special Controls) or Class III (PMA).
Key players are dominating in the global Huber Needles market such as, B. Braun Medical Inc., Baxter International Inc., NIPRO Medical Corporation, Smiths Medical, C. R. Bard, Inc. and AngioDynamics, Inc.
Key players in the global Huber needles market are concentrating on adoption of M&A initiatives to broaden their product range. For instance, in February 2019, B. Braun Medical Inc. acquired Medisystems Streamline Bloodlines business that includes the Streamline Bloodline for the Dialog+ hemodialysis system, Streamline Bloodline for the Fresenius Medical Care hemodialysis system, and Streamline Bloodline Long for the Fresenius Medical Care hemodialysis system.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027